
View larger version (58K):
[in this window]
[in a new window]
|
Fig. 4. Expression of mig-6 encoded mRNAs and proteins.
(A,B) In situ hybridization using a mig-6L-specific
probe showing DTC (d) specific expression (A), and using a probe common for
mig-6S and mig-6L showing expression in the body wall
muscles and other unidentified cells (B). (C-E) From L2 to adult
stages, a mig-6 promoter::gfp transcriptional reporter construct is
expressed in DTCs (d) (C), in body wall muscles (m), in the CAN neuron (can)
(D), in the head mesodermal cell (hmc), in GLR cells (glr) and in coelomocytes
(cc) (E). (F,G) Anti-MIG-6 antibody staining of late embryos
(released from their shells) shows MIG-6 protein is expressed by body wall
muscle primordium (green) in the wild type (F) but not in
mig-6(ev788) (G), whereas control antibody, anti-SAD-1 (orange)
stains nerve ring and ventral nerve cord in both strains. (H) In early
larval stages, anti-MIG-6 antibody stains basement membranes of the gonad
primordium (g), pharynx (ph) and intestine (i). This staining persists
throughout larval and adult stages. (I,J) Anti-MIG-6 antibody
stains basement membrane of the gonad and migrating DTCs (d) of L3 (I) and L4
(J) stages. Enlargement in I shows staining on the DTC. (K,L)
The same basement membranes and DTCs are stained by anti-MIG-6 antibody in
class-s mig-6(ev700) (K) and in mig-6(k177), which displays
a phase 2M DTC defect (L) (see also Fig. S2 in the supplementary material).
Vulvae are indicated by white triangles. Asterisks indicate posterior. Dorsal
is upwards in all panels. Scale bars: 20 µm.
|